CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
105802-84-4 | | pro-leu-ser-arg-thr-leu-ser-val-ala-*ala- lys-lys | C56H103N17O16 | 1270.53 | | |
105806-13-1 | | 4,6-dichloro-5-fluoro-2-methylpyrimidine | | | | |
105806-14-2 | 2-甲基-5-氟-6-氯嘧啶-4-酮 | 6-chloro-5-fluoro-2-methylpyrimidin-4-ol | | | | |
105806-38-0 | 2-(-羟基-1-氧代-1,2,3,4-四氢萘-2-基)乙酸乙酯 | ethyl 2-(6-hydroxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetate | | | | |
1058062-64-8 | 2-(4,4,5,5-四甲基-1,3,2-二氧杂硼杂环戊烷-2-基)-4-(三氟甲基)苯胺 | 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)aniline | | | | |
105807-71-4 | 2-甲基-7-硝基-2h-1,4-苯并噻嗪-3(4h)-酮 | 2-methyl-7-nitro-2h-1,4-benzothiazin-3(4h)-one | | | | |
105807-79-2 | | 7-amino-2-methyl-2h-1,4-benzoxazin-3(4h)-one | | | | |
105807-80-5 | | 6-amino-2-methyl-2h-benzo[b][1,4]oxazin-3(4h)-one | | | | |
105807-83-8 | 7-氨基-2,2-二甲基-2h-苯并[b][1,4]恶嗪-3(4h)-酮 | 7-amino-2,2-dimethyl-2h-benzo[b][1,4]oxazin-3(4h)-one | | | | |
105807-84-9 | 6-氨基-2,2-二甲基-2h-苯并[b][1,4]噁嗪-3(4h)-酮 | 6-amino-2,2-dimethyl-4h-benzo[1,4]oxazin-3-one | | | | |
105808-72-8 | | carboxy-terminated magnetic particles | | | | |
105809-15-2 | | ultramark® 1621 | | | | |
10581-00-7 | | Silane,tribromophenyl- | C6H5Br3Si | 344.90 | | |
10581-02-9 | | phenyl-tributoxy-silane | C18H32O3Si | 324.53 | | |
10581-12-1 | 四甲基醋酸铵 | n,n,n-trimethyl-methanaminiu acetate | C6H15NO2 | 133.19 | | |
10581-16-5 | 2,4-二异氰酸根合-1-甲基-环己烷 | 2,4-diisocyanato-1-methyl-Cyclohexane | C9H12N2O2 | | | |
10581-38-1 | 2,2,6,6-四甲基-4-哌啶酮 一水合物 | | | | | |
10581-69-8 | | cadaverine-1,5-14c dihydrochloride | C5H14N2.2HCl | 175.10 | | |
105812-73-5 | | trans-(4-phenylpiperidin-3-yl)methanol | | | | |
105812-81-5 | (-)反式-4R(4-氟苯基)-3R-羟甲基-1-甲基哌啶 | | | | | |
105813-14-7 | 帕罗西汀杂质c | paroxetine hydrochloride (anhydrous) impurity c | | | | |
1058137-23-7 | | e-3810 | | | | |
105814-56-0 | | hupehenisine | | | | |
105815-87-0 | | barbourgenin | | | | |
105816-04-4 | 那格列奈(H晶型) | trans-d-phenylalanin | C19H27NO3 | 317.43 | | |
105816-05-5 | 那格列奈杂质b | nateglinide impurity b | | | | |
105816-06-6 | | n-[(cis-4-isopropylcyclohexyl)carbonyl]-d-phenylalanine | | | | |
10582-48-6 | | 17-beta-hydroxy-4,5-secooestrane-3,5-dione | | | | |
105825-15-8 | | 1-benzyl-2,2,4-trimethyl-1,2-dihydro-quinoline | | | | |
105826-92-4 | 1h-吲哚-3-羧酸-(3-endo)-8-甲基-8-氮杂双环[3,2,1]辛烷-3-基酯盐酸盐 | (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 1h-indole-3-carboxylate hydrochloride | | | | |
105827-74-5 | | 5-(bromomethyl)-2-fluoropyridine | | | | |
105827-78-9 | | 4,5-dihydro-1-((6-chloro-3-pyridinyl)methyl)-n-nitro-1h-imidazol-2-amin | | | | |
105827-84-7 | | 2-[(6-chloro-pyridin-3-ylmethyl)-amino]-ethanol | | | | |
105827-91-6 | 2-氯-5-氯甲基噻唑 | | C4H3NSCL3 | | | |
105828-41-9 | | imidacloprid impurity 1 | | | | |
105829-49-0 | | n-[(1-methyl-1h-pyrazol-4-yl)methyl]ethane-1,2-diamine | | | | |
10583-73-0 | | 5,6-di-o-acetylascorbic acid | | | | |
10583-85-4 | | 1-butyl-imidazole-2-thio | | | | |
105831-46-7 | | rb 38 a | | | | |
105831-70-7 | | 5-(2-(cyclobutylamino)-1-hydroxyethyl)-, hydrobromide, (+-)-3-benzenediol | | | | |
105832-38-0 | | o-(n-succinimidyl)-n,n,n',n'-tetramethyl uronium bf4 | | | 195-200℃ | |
105836-29-1 | | ethyl 3-bromo-3,3-difluoropropanoate | | | | |
105836-42-8 | | ethyl 3-(2,6-dimethylpiperidin-1-yl)propanoate | | | | |
105836-96-2 | | 2,8-dibromo-dibenzo[1,4]dioxine | C12H6Br2O2 | 341.98 | | |
105836-99-5 | | 1,7-dinitro-phenazin | | | | |
105837-00-1 | | 2,8-dinitro-phenazin | | | | |
105837-04-5 | 7-溴-2-氧代-2h-色烯-3-羧酸乙酯 | ethyl 7-bromo-2-oxo-2h-chromene-3-carboxylate | | | | |
105838-14-0 | | n-boc-o-tosylhydroxylamine | | | | |
105838-44-6 | | 2-cyclohexyl-bicyclopropyl | C12H20 | 164.29 | | |
105838-47-9 | | (±)-3a,5,6-trimethyl-cis-2,3,3a,4,7,7a-hexahydro-indene | C12H20 | 164.29 | | |